Connect
MJA
MJA

Junk DNA and the identification of new levels of evidence to guide medical practice in 2013 and beyond

Peter D Jones
Med J Aust 2012; 197 (11): . || doi: 10.5694/mja12.11513
Published online: 10 December 2012

To the Editor: This year, evidence-based medicine celebrated its 20th birthday.1 However, it remains difficult to translate research findings to the bedside,2 and many medical diagnoses and treatments are unable to meet the five levels of clinical evidence currently recognised in the United Kingdom (http://evidence basedmedicine.com.au/?page_id=30).


  • School of Medicine, Bond University, Gold Coast, QLD.


Correspondence: pejones@bond.edu.au

Competing interests:

No relevant disclosures.

  • 1. Cook DJ, Jaeschke R, Guyatt GH. Critical appraisal of therapeutic interventions in the intensive care unit: human monoclonal antibody treatment in sepsis: Journal Club of the Hamilton Regional Critical Care Group. J Intensive Care Med 1992; 7: 275-282.
  • 2. Scott IA, Glasziou PP. Improving the effectiveness of clinical medicine: the need for better translation of science into practice. Med J Aust 2012; 197: 374-378. <MJA full text>
  • 3. The Encode Consortium. An integrated encyclopaedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
  • 4. Jones PD. Medical Munchausen syndrome. Lancet 1995; 345: 995.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.